 BOSTON, Sept. 06, 2022 GLOBE NEWSWIRE -- Galecto, Inc. NASDAQ: GLTO, a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced that management will be participating at the upcoming H.C. Wainwrights 24th Annual Global Investment Conference taking place on September 12-14, 2022. Details for the event are as follows: 